Get the Stockscreener App
1.26
0.80%
0.01
After Hours:
1.28
0.02
+1.59%
Treace Medical Concepts Inc stock is traded at $1.26, with a volume of 355.97K.
It is up +0.80% in the last 24 hours and down -38.24% over the past month.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
See More
Previous Close:
$1.25
Open:
$1.28
24h Volume:
355.97K
Relative Volume:
0.43
Market Cap:
$81.38M
Revenue:
$212.69M
Net Income/Loss:
$-59.00M
P/E Ratio:
-1.3495
EPS:
-0.9337
Net Cash Flow:
$-29.49M
1W Performance:
-6.67%
1M Performance:
-38.24%
6M Performance:
-81.14%
1Y Performance:
-85.18%
1-Day Range:
$1.24
$1.32
1-Week Range:
$1.185
$1.39
52-Week Range:
$1.185
$8.87
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts Inc
Sector
Industry
Phone
(904) 373-5940
Address
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
1.26 | 80.74M | 212.69M | -59.00M | -29.49M | -0.9337 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-07-25 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-07-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Feb-04-25 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-31-24 | Initiated | Lake Street | Buy |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| May-16-24 | Downgrade | UBS | Buy → Neutral |
| May-08-24 | Downgrade | BTIG Research | Buy → Neutral |
| May-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-08-24 | Downgrade | Stifel | Buy → Hold |
| May-08-24 | Downgrade | Truist | Buy → Hold |
| Sep-29-23 | Initiated | UBS | Buy |
| May-01-23 | Initiated | Truist | Buy |
| Apr-11-23 | Initiated | Stephens | Equal-Weight |
| May-12-22 | Initiated | BTIG Research | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-18-21 | Initiated | JP Morgan | Overweight |
| May-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-21 | Initiated | SVB Leerink | Outperform |
| May-18-21 | Initiated | Stifel | Buy |
View All
Treace Medical Concepts Inc Stock (TMCI) Latest News
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Connect - ACCESS Newswire
2026-03-22 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Connect | NDAQ:TMCI | Press Release - Stockhouse
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2025 earnings call transcript - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Quarterly Earnings: Is Treace Medical Concepts Inc gaining market shareWeekly Trading Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
CIBC Bancorp USA Inc. Acquires New Stake in Treace Medical Concepts, Inc. $TMCI - MarketBeat
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $4.77 Average PT from Analysts - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Class Action Filed Against Treace Medical Concepts, Inc. (TMCI)June 10, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Treace Medical Concepts, Inc.Common Stock (NQ: TMCI - The Chronicle-Journal
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Recommendation of "Reduce" from Analysts - MarketBeat
How Treace Medical Concepts Inc. (TMCI) Affects Rotational Strategy Timing - Stock Traders Daily
Resistance Check: Is Treace Medical Concepts Inc gaining market shareMarket Trend Summary & Technical Buy Zone Confirmations - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Investors to Inquire about Securities Investigation - ACCESS Newswire
Treace Medical (TMCI) legal chief reports routine tax share withholding - Stock Titan
Treace Medical Concepts (TMCI) CFO has 4,659 shares withheld for taxes - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Reach Out - ACCESS Newswire
Treace Medical Concepts (TMCI) executive has 1,797 shares withheld for taxes - Stock Titan
Market Catalysts: Why is Treace Medical Concepts Inc stock going up2025 Sector Review & Verified Momentum Stock Alerts - baoquankhu1.vn
Treace Medical Concepts Hits New 52-Week Low at $1.58 - Markets Mojo
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2025 Earnings Call Transcript - Insider Monkey
Treace Medical Concepts (NASDAQ:TMCI) Given New $7.00 Price Target at Lake Street Capital - Defense World
Analysts Are Neutral on Top Healthcare Stocks: Amgen (AMGN), Treace Medical Concepts (TMCI) - The Globe and Mail
Treace Medical Concepts (NASDAQ:TMCI) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
TMCI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Treace Medical Earnings Call Balances Progress and Pressure - TipRanks
Lake Street Capital Issues Pessimistic Forecast for Treace Medical Concepts (NASDAQ:TMCI) Stock Price - MarketBeat
Treace Medical Concepts Q4 Earnings Call Highlights - Defense World
Truist Securities Adjusts Treace Medical Concepts PT to $2 From $3, Maintains Hold Rating - marketscreener.com
Treace Medical net loss hits USD 9.4M in Q4 2025 - Medical Buyer
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Treace Medical Concepts, Inc. (TMCI): Investor Outlook Reveals Potential 100% Upside - DirectorsTalk Interviews
Treace Medical Concepts (NASDAQ:TMCI) Issues Quarterly Earnings Results - MarketBeat
Treace Medical Concepts Inc (TMCI) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Is Treace Medical Concepts Inc gaining market shareEarnings Growth Report & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Earnings call transcript: Treace Medical Concepts Q4 2025 reports revenue decline, stock edges up - Investing.com Canada
Treace Medical Concepts Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Treace Medical Concepts earnings missed, revenue topped estimates By Investing.com - Investing.com Canada
Treace Medical Concepts, Inc. Provides Revenue Guidance for the Full Year 2026 - marketscreener.com
Treace Medical Concepts, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
TREACE MEDICAL CONCEPTS, INC. SEC 10-K Report - TradingView
Treace Medical Concepts: Q4 Earnings Snapshot - marketscreener.com
Treace Medical Concepts (NASDAQ: TMCI) posts 2025 loss and guides flat-to-down 2026 sales - Stock Titan
Treace Medical Concepts Q4 Earnings Summary & Key Takeaways - Benzinga
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results - Caledonian Record
Earnings Call Summary | Treace Medical Concepts(TMCI.US) Q4 2025 Earnings Conference - 富途牛牛
Treace Medical Concepts Q4 2025 Earnings Call Transcript - MarketBeat
Treace Medical Concepts: Fourth Quarter Financial Results Overview - Bitget
Treace Medical Concepts's Earnings: A Preview - Benzinga
Treace Medical Concepts Inc Stock (TMCI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):